COSMOS HEALTH NEW DL-01
Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, Croatia, Bulgaria, the United Arab Emirates, the United Kingdom, and Cyprus. The company offers prescription medications, over-the-counter drugs, medical devices, food supplements, nutraceuticals, cosmetics and other healthcare products under the Sky Premium Life and Mediterranation brand names. It als… Read more
Market Cap & Net Worth: COSMOS HEALTH NEW DL-01 (V67A)
COSMOS HEALTH NEW DL-01 (F:V67A) has a market capitalization of $10.62 Million (€10.34 Million) as of March 19, 2026. Listed on the F stock exchange, this Germany-based company holds position #29510 globally and #3258 in its home market, demonstrating a -3.64% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying COSMOS HEALTH NEW DL-01's stock price €0.30 by its total outstanding shares 34919920 (34.92 Million).
COSMOS HEALTH NEW DL-01 Market Cap History: 2022 to 2026
COSMOS HEALTH NEW DL-01's market capitalization history from 2022 to 2026. Data shows change from $150.98 Million to $10.62 Million (-66.52% CAGR).
COSMOS HEALTH NEW DL-01 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how COSMOS HEALTH NEW DL-01's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of V67A by Market Capitalization
Companies near COSMOS HEALTH NEW DL-01 in the global market cap rankings as of March 19, 2026.
Key companies related to COSMOS HEALTH NEW DL-01 by market ranking:
- McKesson Corporation (NYSE:MCK): Ranked #165 globally with a market cap of $115.21 Billion USD.
- Cencora Inc. (NYSE:COR): Ranked #350 globally with a market cap of $62.31 Billion USD.
- Cardinal Health Inc (NYSE:CAH): Ranked #430 globally with a market cap of $50.81 Billion USD.
- Sigma Healthcare Limited (OTCGREY:SIGGF): Ranked #1462 globally with a market cap of $12.16 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #165 | McKesson Corporation | NYSE:MCK | $115.21 Billion | $941.89 |
| #350 | Cencora Inc. | NYSE:COR | $62.31 Billion | $334.71 |
| #430 | Cardinal Health Inc | NYSE:CAH | $50.81 Billion | $216.36 |
| #1462 | Sigma Healthcare Limited | OTCGREY:SIGGF | $12.16 Billion | $1.88 |
COSMOS HEALTH NEW DL-01 Historical Marketcap From 2022 to 2026
Between 2022 and today, COSMOS HEALTH NEW DL-01's market cap moved from $150.98 Million to $ 10.62 Million, with a yearly change of -66.52%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €10.62 Million | -27.93% |
| 2025 | €14.73 Million | -35.73% |
| 2024 | €22.92 Million | -51.92% |
| 2023 | €47.67 Million | -68.42% |
| 2022 | €150.98 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of COSMOS HEALTH NEW DL-01 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $10.62 Million USD |
| MoneyControl | $10.62 Million USD |
| MarketWatch | $10.62 Million USD |
| marketcap.company | $10.62 Million USD |
| Reuters | $10.62 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.